|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2002-12-18
|
|
pubmed:abstractText |
To identify clinical and biologic variables with significant impact on survival in patients with carcinomas of an unknown primary site and to develop a simple prognostic model for the selection of patients in prospective clinical trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4679-83
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12488413-Analysis of Variance,
pubmed-meshheading:12488413-Female,
pubmed-meshheading:12488413-Humans,
pubmed-meshheading:12488413-L-Lactate Dehydrogenase,
pubmed-meshheading:12488413-Liver Neoplasms,
pubmed-meshheading:12488413-Male,
pubmed-meshheading:12488413-Middle Aged,
pubmed-meshheading:12488413-Models, Statistical,
pubmed-meshheading:12488413-Neoplasms, Unknown Primary,
pubmed-meshheading:12488413-Prognosis,
pubmed-meshheading:12488413-Survival Rate
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site.
|
|
pubmed:affiliation |
Centre Régional de Lutte Contre le Cancer Val d'Aurelle, Montpellier, France. stculine@valdorel.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article
|
